메뉴 건너뛰기




Volumn 19, Issue 3, 2011, Pages 1242-1255

Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship

Author keywords

Asthma; COPD; DOA; IKK 2; Inhaled approach; Inhibitors; Potent; Selective

Indexed keywords

1 (3 CHLORO 4 HYDROXYPHENYL) 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 1 (4 CHLORO 3 HYDROXYPHENYL) 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 1 (4 {[3 CARBAMOYL 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]CARBAMOYL} 5 CHLOROPYRIDIN 2 YL) 4 [(1 METHYL 1H PYRAZOL 4 YL)METHYL]PIPERAZINE 2 CARBOXYLIC ACID; 4 (4 {[3 CARBAMOYL 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]CARBAMOYL} 5 CHLOROPYRIDIN 2 YL) 1 [(1 METHYL 1H PYRAZOL 4 YL)METHYL]PIPERAZINE 2 CARBOXYLIC ACID; 8 (5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINAMIDO) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 ({5 CHLORO 2 [4 ({1 [2 (DIMETHYLAMINO) 2 OXOETHYL] 1H PYRAZOL 4 YL}METHYL)PIPERAZIN 1 YL]ISONICOTINOYL}AMINO) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 ({5 CHLORO 2 [4 ({1 [2 (ISOPROPYLAMINO) 2 OXOETHYL] 1H PYRAZOL 4 YL}METHYL)PIPERAZIN 1 YL]ISONICOTINOYL}AMINO) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 ({5 CHLORO 2 [4 ({1 [3 (2 METHOXYETHOXY)PROPYL] 1H PYRAZOL 4 YL}METHYL)PIPERAZIN 1 YL]ISONICOTINOYL}AMINO) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 ({5 CHLORO 2 [4 ({1 [3 (DIMETHYLAMINO)PROPYL] 1H PYRAZOL 4 YL}METHYL)PIPERAZIN 1 YL]ISONICOTINOYL}AMINO) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 [(5 CHLORO 2 {(3) 3 METHYL 4 [(1 METHYL 1H PYRAZOL 4 YL)METHYL]PIPERAZIN 1 YL}ISONICOTINOYL)AMINO] 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 [(5 CHLORO 2 {4 [(1 METHYL 1H PYRAZOL 4 YL)METHYL]PIPERAZIN 1 YL}ISONICOTINOYL)AMINO] 1 (3 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 [(5 CHLORO 2 {4 [(1 METHYL 1H PYRAZOL 4 YL)METHYL]PIPERAZIN 1 YL}ISONICOTINOYL)AMINO] 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 [(5 CHLORO 2 {4 [(1 {2 [(2 METHOXYETHYL)AMINO] 2 OXOETHYL} 1H PYRAZOL 4 YL)METHYL]PIPERAZIN 1 YL}ISONICOTINOYL)AMINO] 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G] INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL] AMINO} 1 (3 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (3 HYDROXYPHENYL) 4,5 DIHYDRO 1H BENZO[G] INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (3,4 DIFLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 HYDROXYPHENYL) 4,5 DIHYDRO 1H BENZO[G] INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 METHYLPIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 METHOXYPHENYL) 4,5 DIHYDRO 1H BENZO[G] INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 {[1 (2 CYANOETHYL) 1H PYRAZOL 4 YL]METHYL}PIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 {[1 (2 {[2 (METHYLTHIO)ETHYL] AMINO} 2 OXOETHYL) 1H PYRAZOL 4 YL]METHYL}PIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 {[1 (3 HYDROXYPROPYL) 1H PYRAZOL 4 YL]METHYL}PIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; 8 {[5 CHLORO 2 (4 {[1 (3 METHOXYPROPYL) 1HPYRAZOL 4 YL]METHYL}PIPERAZIN 1 YL)ISONICOTINOYL]AMINO} 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOLE 3 CARBOXAMIDE; AMIDE; AMINOPYRIDINE DERIVATIVE; ETHYL 3 [4 ({4 [4 ({[3 (AMINOCARBONYL) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]AMINO}CARBONYL) 5 CHLOROPYRIDIN 2 YL]PIPERAZIN 1 YL}METHYL) 1H PYRAZOL 1 YL]PROPANOATE; ETHYL [4 ({4 [4 ({[3 (AMINOCARBONYL) 1 (3 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]AMINO} CARBONYL) 5 CHLOROPYRIDIN 2 YL]PIPERAZIN 1 YL}METHYL) 1H PYRAZOL 1 YL]ACETATE; ETHYL [4 ({4 [4 ({[3 (AMINOCARBONYL) 1 (4 FLUOROPHENYL)4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]AMINO}CARBONYL) 5 CHLOROPYRIDIN 2 YL]PIPERAZIN 1 YL}METHYL) 1H PYRAZOL 1 YL]ACETATE; I KAPPA B KINASE INHIBITOR; METHYL [4 ({4 [4 ({[3 (AMINOCARBONYL) 1 (4 FLUOROPHENYL) 4,5 DIHYDRO 1H BENZO[G]INDAZOL 8 YL]AMINO}CARBONYL) 5 CHLOROPYRIDIN 2 YL]PIPERAZIN 1 YL}METHYL) 1H PYRAZOL 1 YL]ACETATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 79551496434     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.12.027     Document Type: Article
Times cited : (13)

References (42)
  • 11
    • 79551470115 scopus 로고    scopus 로고
    • WO 2003010163 A1 20030206
    • Griffiths, D.; Johnstone, C., 2003, WO 2003010163 A1 20030206.
    • (2003)
    • Griffiths, D.1    Johnstone, C.2
  • 14
    • 79551471381 scopus 로고    scopus 로고
    • PCT Int. Appl. WO 2007076286 A2
    • Kerns, J. K.; PCT Int. Appl. WO 2007076286 A2, 2007.
    • (2007)
    • Kerns, J.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.